A policy framework for leveraging generative AI to address enduring challenges in clinical trials
Can artificial intelligence improve clinical trial design? Despite their importance in medicine, over 40% of trials involve flawed protocols. We introduce and propose the development of application-specific language models (ASLMs) for clinical trial design…
Continue Reading